Artiva Biotherapeutics, Inc. (ARTV)

SEC filing

Artiva Biotherapeutics, Inc.

ARTV · CIK 1817241

4 · Oct 6, 2026 · Chief Tech Operations Officer Horan Christopher sold 10.34K shares at $6.84/share ($70,697)

Chief Tech Operations Officer Horan Christopher sold 10.34K shares at $6.84/share ($70,697)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).